174 related articles for article (PubMed ID: 35903699)
1. Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
Li G; Jiang Y
Front Oncol; 2022; 12():916790. PubMed ID: 35903699
[TBL] [Abstract][Full Text] [Related]
2. Multiple Somatic Mutations of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: A Case Report.
Aoyagi Y; Kai K; Nishida H; Aso S; Kobayashi E
Cureus; 2024 May; 16(5):e60802. PubMed ID: 38903333
[TBL] [Abstract][Full Text] [Related]
3. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond
Auguste A; Blanc-Durand F; Deloger M; Le Formal A; Bareja R; Wilkes DC; Richon C; Brunn B; Caron O; Devouassoux-Shisheboran M; Gouy S; Morice P; Bentivegna E; Sboner A; Elemento O; Rubin MA; Pautier P; Genestie C; Cyrta J; Leary A
Cells; 2020 Jun; 9(6):. PubMed ID: 32575483
[TBL] [Abstract][Full Text] [Related]
4. Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
Ramos P; Karnezis AN; Hendricks WP; Wang Y; Tembe W; Zismann VL; Legendre C; Liang WS; Russell ML; Craig DW; Farley JH; Monk BJ; Anthony SP; Sekulic A; Cunliffe HE; Huntsman DG; Trent JM
Rare Dis; 2014; 2(1):e967148. PubMed ID: 26942101
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.
Lin DI; Chudnovsky Y; Duggan B; Zajchowski D; Greenbowe J; Ross JS; Gay LM; Ali SM; Elvin JA
Gynecol Oncol; 2017 Dec; 147(3):626-633. PubMed ID: 29102090
[TBL] [Abstract][Full Text] [Related]
6. Small Cell Carcinoma of Ovary, Hypercalcemic Type: Cytologic, Histopathologic, and Immunohistochemical Landscapes of a Rare Case.
Aggarwal D; Gupta P; Chhabra P; Peters NJ; Bansal D; Srinivasan R; Kakkar N
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):98-102. PubMed ID: 32750414
[TBL] [Abstract][Full Text] [Related]
7. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
[TBL] [Abstract][Full Text] [Related]
8. Remarkable Response to the Triplet Combination of Olaparib with Pembrolizumab and Bevacizumab in the Third-Line Treatment of an Ovarian Clear Cell Carcinoma Patient with an ARID1A Mutation: A Case Report.
Zhao Y; Jiang Y
Onco Targets Ther; 2022; 15():323-328. PubMed ID: 35401005
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type.
Stephens B; Anthony SP; Han H; Kiefer J; Hostetter G; Barrett M; Von Hoff DD
J Cancer; 2012; 3():58-66. PubMed ID: 22315651
[TBL] [Abstract][Full Text] [Related]
10. Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT).
Blanc-Durand F; Lefeuvre-Plesse C; Ray-Coquard I; Chaltiel D; Floquet A; Meriaux É; Berton D; Bello-Roufai D; Guillemet C; Dupre PF; Faller É; Alexandre J; Hardy-Bressard AC; Collard O; Fabbro M; Provansal M; Kalbacher E; Genestie C; Pautier P
Gynecol Oncol; 2020 Oct; 159(1):129-135. PubMed ID: 32723678
[TBL] [Abstract][Full Text] [Related]
11. Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
Bailey S; Murray MJ; Witkowski L; Hook E; Hasselblatt M; Crawford R; Foulkes WD; Tischkowitz M; Nicholson JC
Pediatr Blood Cancer; 2015 Apr; 62(4):728-30. PubMed ID: 25307865
[TBL] [Abstract][Full Text] [Related]
12. An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Clinical Implications from Recent Molecular Findings.
Lu B; Shi H
J Cancer; 2019; 10(1):223-237. PubMed ID: 30662543
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report.
Zhong L; Liu X; Li Z; Zhang X; Wang Y; Peng W
Front Oncol; 2021; 11():783158. PubMed ID: 35096582
[TBL] [Abstract][Full Text] [Related]
14. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.
Sanders BE; Wolsky R; Doughty ES; Wells KL; Ghosh D; Ku L; Pressey JG; Bitler BB; Brubaker LW
Gynecol Oncol Rep; 2022 Dec; 44():101077. PubMed ID: 36249907
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.
Zhang B; Qi L; Wang X; Xu J; Liu Y; Mu L; Wang X; Bai L; Huang J
Cancer Commun (Lond); 2020 Dec; 40(12):711-720. PubMed ID: 33314747
[TBL] [Abstract][Full Text] [Related]
16. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
Witkowski L; Goudie C; Ramos P; Boshari T; Brunet JS; Karnezis AN; Longy M; Knost JA; Saloustros E; McCluggage WG; Stewart CJR; Hendricks WPD; Cunliffe H; Huntsman DG; Pautier P; Levine DA; Trent JM; Berchuck A; Hasselblatt M; Foulkes WD
Gynecol Oncol; 2016 Jun; 141(3):454-460. PubMed ID: 26975901
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.
Connor YD; Miao D; Lin DI; Hayne C; Howitt BE; Dalrymple JL; DeLeonardis KR; Hacker MR; Esselen KM; Shea M
Gynecol Oncol; 2020 Apr; 157(1):106-114. PubMed ID: 31954538
[TBL] [Abstract][Full Text] [Related]
18. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
Ramos P; Karnezis AN; Craig DW; Sekulic A; Russell ML; Hendricks WP; Corneveaux JJ; Barrett MT; Shumansky K; Yang Y; Shah SP; Prentice LM; Marra MA; Kiefer J; Zismann VL; McEachron TA; Salhia B; Prat J; D'Angelo E; Clarke BA; Pressey JG; Farley JH; Anthony SP; Roden RB; Cunliffe HE; Huntsman DG; Trent JM
Nat Genet; 2014 May; 46(5):427-9. PubMed ID: 24658001
[TBL] [Abstract][Full Text] [Related]
19. Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature.
Rao V; Bauer F; Vredenburgh JJ
Conn Med; 2016 Oct; 80(9):529-532. PubMed ID: 29772136
[TBL] [Abstract][Full Text] [Related]
20. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome-A Systematic Review.
Wens FSPL; Hulsker CCC; Fiocco M; Zsiros J; Smetsers SE; de Krijger RR; van der Steeg AFW; Zweemer RP; Baas IO; Roes EM; Looijenga LHJ; Gerestein CG; Mavinkurve-Groothuis AMC
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
